Global Insulin Pump
Market Report
2025
The global insulin pump market will be USD 6251.8 million in 2025. Rising diabetes prevalence worldwide and increasing adoption of advanced insulin delivery systems are expected to boost sales to USD 12457.10 million by 2033, with a Compound Annual Growth Rate (CAGR) of 9.00% from 2025 to 2033.
The base year for the calculation is 2024. The historical will be 2021 to 2024. The year 2025 will be estimated one while the forecasted data will be from year 2025 to 2033. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
Share your contact details to receive free updated sample copy/pages of the recently published edition of Insulin Pump Market Report 2025.
According to Cognitive Market Research, the global Insulin Pumps Market size will be USD 6251.8 million in 2025. It will expand at a compound annual growth rate (CAGR) of 9.00% from 2025 to 2033.
2024 | 2025 | 2032 | 2033 | CAGR | |
---|---|---|---|---|---|
Global Insulin Pump Market Sales Revenue | 121212 | 121212 | 121212 | 121212 | 16.4% |
Base Year | 2024 |
Historical Data Time Period | 2021-2024 |
Forecast Period | 2025-2033 |
Market Split by Type Outlook: |
|
Market Split by Product Outlook: |
|
Market Split by Accessories Outlook: |
|
Market Split by Application Outlook: |
|
List of Competitors |
|
Regional Analysis |
|
Country Analysis |
|
Market Drivers:
| |
Market Restrains:
| |
Market Trends:
|
Report scope is customizable as we have a huge database of Insulin Pump industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Insulin Pump Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
The worldwide market for insulin pumps has experienced considerable growth over the last few years, fueled mostly by the growing rate of diabetes and technological innovation in medical devices. As per the Centers for Disease Control and Prevention (CDC), more than 38.4 million individuals in the United States alone were diagnosed with diabetes as of 2022, underscoring the critical need for efficient and persistent glucose management technology. Insulin pumps provide a user-friendly alternative to multiple daily injections by providing accurate insulin doses and, hence, enhancing glycemic control and long-term complications. Government healthcare agencies, such as the National Institutes of Health (NIH), have underscored the need for insulin pump therapy in enhancing patient compliance and quality of life, particularly in type 1 diabetes patients. In addition, the American Diabetes Association (ADA) supports the use of insulin pumps as an optimal way to deliver intensive insulin therapy to those in need. Advances in technology, including integration with continuous glucose monitoring (CGM) systems and automated delivery algorithms for insulin, are further driving market penetration. With expanding awareness, positive payment policies, and rising diabetic populations worldwide, the insulin pumps market is set to continue growing.
In August 2024, Medtronic received FDA approval for its Simplera™ continuous glucose monitor (CGM) and announced a global partnership with Abbott to expand CGM options for people living with diabetes.? https://investors.insulet.com/news/news-details/2024/Insulet-Announces-Full-Commercial-Launch-of-Omnipod-5-with-Expanded-Sensor-Integrations-in-the-United-Kingdom-and-the-Netherlands/default.aspx
Based on the Centers for Disease Control and Prevention (CDC), the prevalence of Americans diagnosed with diabetes has increased significantly, with more than 38.4 million individuals in the United States reported to have diabetes in 2021, and around 1.6 million Americans with Type 1 diabetes, the major population that uses insulin pumps. The growing incidence of Type 1 and insulin-dependent Type 2 diabetes has greatly increased the potential user population for insulin pumps. They provide accurate insulin delivery, enhanced glycemic control, and fewer episodes of hypoglycemia, making them a choice for long-term management of diabetes. The CDC's National Diabetes Statistics Report indicates the increasing population of diabetics, especially among children and youths, is promoting early and sophisticated treatment alternatives such as insulin pumps. Therefore, public health efforts also emphasize patient education on pioneering technologies, which indirectly contribute to market growth. The correlation between government-reported diabetes figures and rising medical technology use mirrors the dominant role played by public health information in shaping demand for insulin pumps.
Government authorities around the world are actively developing healthcare infrastructure and providing funding to diabetes care programs, which largely boosts the growth of the insulin pumps market. For example, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the U.S. Department of Health and Human Services (HHS) has been investing in developing cutting-edge research and technology in diabetes management. Programs like the Special Statutory Funding Program for Type 1 Diabetes Research center on developing artificial pancreas systems and enhancing insulin delivery technologies. These programs not only subsidize R&D but also enhance awareness and availability of advanced treatment modalities such as insulin pumps. Furthermore, the Centers for Medicare & Medicaid Services (CMS) have broadened coverage for durable medical equipment, such as insulin pumps, making them cheaper and more accessible to covered patients. Such policy support favorably impacts patient uptake and prompts manufacturers to develop and serve a larger population. This synergy of government investment, facilitating policies, and investments in infrastructure serves as a significant driver for the insulin pumps market.
One of the key constraints against the growth in the insulin pumps market is the devices' high expense and restricted reimbursement policies, most notably in developing and middle-income countries. For the World Health Organization (WHO), although increasing diabetes technology progress is enhancing treatment outcomes, this access is becoming increasingly unevenly distributed across regional areas. Insulin pumps, which may be in the range of thousands of dollars per year in terms of supplies and maintenance, are prohibitive for much of the population in developing countries. In addition, few national health systems provide comprehensive insurance benefits or reimbursement for insulin pumps, which restricts patient access to these life-saving technologies. The WHO's "Global Diabetes Compact" report highlights that universal access to diabetes care, including newer therapies such as insulin pumps, is still a challenge owing to cost and systemic constraints. Consequently, despite their clinical advantages, adoption rates of insulin pumps are still low in countries other than high-income nations, thus hindering the overall market growth.
One of the key trends driving the insulin pumps market is the integration of artificial intelligence (AI) and smart technologies to improve diabetes care and patient experience. According to the U.S. Food and Drug Administration (FDA), the evolution of sophisticated insulin delivery systems with predictive algorithms and continuous glucose monitoring (CGM) integration is moving ahead quickly. These advances are making insulin pumps more intelligent and responsive through the automatic control of insulin delivery as a function of real-time glucose levels. Hybrid closed-loop systems, or artificial pancreas devices, are, for instance, employing AI-powered data to control glucose within target ranges with limited user intervention. The FDA has already approved multiple such systems, and there is encouragement to do more research and development along this line. This technological advancement is enhancing glycemic control, decreasing hypoglycemic events, and making daily diabetes care easier for patients. With more regulatory approval and market acceptance of AI-powered devices, this trend is likely to fuel the next phase of growth and innovation in the insulin pumps market.
Another key trend in the insulin pumps market is increased demand for tubeless and wearable insulin pump devices, fueled by patient preference for convenience, comfort, and discretion. Data from the National Institutes of Health (NIH) indicates that technological advancements in wireless technology and microfluidics have made it possible to create small, patch-based insulin delivery systems that stick to the skin without tubing. These wearable products make the administration of insulin more convenient, facilitate mobility, and minimize the social stigma usually seen with conventional insulin delivery systems. The NIH also points out that such technology increases user compliance and satisfaction, especially among young, active patients. Moreover, the devices tend to be equipped with smartphone connectivity to enable real-time monitoring and control, which is driving their acceptance on a broad scale. As patients are growing more concerned about lifestyle compatibility and convenience, the trend towards wearable and tubeless insulin pumps should continue to be a dominant growth pattern in the worldwide market.
We have various report editions of Insulin Pump Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
The Insulin Pumps Market is highly competitive, characterized by the presence of several global and regional players offering a wide range of products. Key companies in the market, such as Medtronic, Hoffmann-La Roche AG, Tandem Diabetes Care, Inc., Insulet Corporation, Ypsomed, Sanofi S.A., Sooil development, Jiangsu Delfu Co., Ltd., Cellnovo Ltd, Valeritas, Inc, dominate through their extensive product portfolios, strong distribution networks, and focus on innovation.
In July 2024, Switch Mobility Automotive Ltd. partnered with Vertelo to deploy 1,000 electric buses and light commercial vehicles in India over the next three years. This initiative supports the growing electrification of transportation in the region. The expansion of electric cars will likely increase demand for components like automotive junction boxes, which are essential for electrical management in EVs. https://investors.insulet.com/news/news-details/2024/Insulet-Announces-Full-Commercial-Launch-of-Omnipod-5-with-Expanded-Sensor-Integrations-in-the-United-Kingdom-and-the-Netherlands/default.aspx In March 2025, Tandem Diabetes Care received FDA clearance for its Control-IQ+ technology, designed for use by individuals with type 2 diabetes aged 18 and older. https://investor.tandemdiabetes.com/news-releases/news-release-details/tandem-diabetes-care-announces-fda-clearance-control-iq
Top Companies Market Share in Insulin Pump Industry: (In no particular order of Rank)
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
According to Cognitive Market Research, North America currently dominates the Insulin Pumps Market by virtue of high diabetes prevalence rates and superior healthcare infrastructure. In 2022, according to the Centers for Disease Control and Prevention (CDC), nearly 37.3 million Americans have diabetes, representing 11.3% of the American population. With such a massive patient base requiring diabetes management instruments like insulin pumps, the demand here is fueling the market. Also, the market growth is bolstered by the presence of major players and relentless technological progress. The region's well-established reimbursement mechanisms and private insurance markets further facilitate patient access to these devices, reinforcing North America's leading position in the global insulin pump market.?
The Asia-Pacific region is seeing the fastest development in the market for insulin pumps, stimulated by a growing population of people with diabetes and strengthening healthcare infrastructure. For instance, according to a 2023 report from the Indian Council of Medical Research (ICMR), India has an estimated 101 million people living with diabetes, accounting for 11.4% of the country's population. This rising prevalence points to the growing demand for efficient solutions for managing diabetes, like insulin pumps. Government programs to improve healthcare infrastructure and raise awareness regarding diabetes care are also driving market growth. In addition, the increasing population of geriatric patients who are more prone to diabetes increases the demand for insulin pumps in the region. All these factors combined make Asia-Pacific a fast-growing market for the adoption of insulin pumps.
The current report Scope analyzes Insulin Pump Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
According to Cognitive Market Research, the global Insulin Pumps Market size was estimated at USD 3915.4 Million, out of which North America held the major market share of more than 37% of the global revenue with a market size of USD 2313.17 million in 2025 and will grow at a compound annual growth rate (CAGR) of 6.8% from 2025 to 2033.
According to Cognitive Market Research, the US had a major share in the Insulin Pumps Market with a market size of USD 1825.09 million in 2025 and is projected to grow at a CAGR of 6.6% during the forecast period. Increasing awareness of diabetes self-management is encouraging patients to adopt advanced insulin delivery devices.
The Canadian Insulin Pumps Market had a market share of USD 277.58 million in 2025 and is projected to grow at a CAGR of 7.6% during the forecast period. Technological innovations such as smart insulin pumps with CGM integration are improving patient outcomes.
The Mexico Insulin Pumps Market is projected to witness growth at a CAGR of 7.3% during the forecast period, with a market size of USD 210.50 million in 2025.
According to Cognitive Market Research, the global Insulin Pumps Market size was estimated at USD 3185.7 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 1813.02 million in 2025 and will grow at a compound annual growth rate (CAGR) of 7.3% from 2025 to 2033.
The United Kingdom Insulin Pumps Market had a market share of USD 304.59 million in 2025 and is projected to grow at a CAGR of 8.1% during the forecast period. A growing geriatric population is contributing to a higher incidence of diabetes and insulin dependency.
The France Insulin Pumps Market is projected to witness growth at a CAGR of 6.5% during the forecast period, with a market size of USD 166.80 million in 2025.
According to Cognitive Market Research, the German Insulin Pumps Market was valued at USD 358.98 million in 2025 and is projected to grow at a CAGR of 7.5% during the forecast period. Sedentary lifestyles and dietary habits are leading to an increase in Type 2 diabetes cases globally./P>
The Italy Insulin Pumps Market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD 155.92 million in 2025.
The Russia Insulin Pumps Market is projected to witness growth at a CAGR of 6.3% during the forecast period, with a market size of USD 281.02 million in 2025
The Spain Insulin Pumps Market is projected to witness growth at a CAGR of 6.4% during the forecast period with a market size of USD 148.67 million in 2025
The Sweden Insulin Pumps Market is projected to witness growth at a CAGR of 7.4% during the forecast period, with a market size of USD 56.20 million in 2025.
The Denmark Insulin Pumps Market is projected to witness growth at a CAGR of 7.1% during the forecast period, with a market size of USD 38.07 million in 2025
The Switzerland Insulin Pumps Market is projected to witness growth at a CAGR of 7.0% during the forecast period, with a market size of USD 27.20 million in 2025.
The Luxembourg Insulin Pumps Market is projected to witness growth at a CAGR of 7.6% during the forecast period, with a market size of USD 21.76 million in 2025.
The Rest of Europe's Insulin Pumps Market is projected to witness growth at a CAGR of 6.0% during the forecast period, with a market size of USD 253.82 million in 2025.
According to Cognitive Market Research, the global Insulin Pumps Market size was estimated at USD 3457.8 million, out of which APAC held the market share of around 23% of the global revenue with a market size of USD 1500.43 million in 2025 and will grow at a compound annual growth rate (CAGR) of 11.0% from 2025 to 2033.
According to Cognitive Market Research, the China Insulin Pumps Market size was valued at USD 630.18 million in 2025 and is projected to grow at a CAGR of 10.5% during the forecast period. Increased demand for wearable and portable medical devices is favoring the use of insulin pumps.
The Japan Insulin Pumps Market is projected to witness growth at a CAGR of 9.5% during the forecast period, with a market size of USD 207.06 million in 2025
The South Korea Insulin Pumps Market had a market share of USD 180.05 million in 2025 and is projected to grow at a CAGR of 10.1% during the forecast period. The availability of personalized insulin dosing options is appealing to health-conscious consumers.
The Indian Insulin Pumps Market is projected to witness growth at a CAGR of 12.9% during the forecast period, with a market size of USD 150.04 million in 2025.
The Australian Insulin Pumps Market is projected to witness growth at a CAGR of 10.3% during the forecast period, with a market size of USD 78.02 million in 2025.
The Singapore Insulin Pumps Market is projected to witness growth at a CAGR of 11.3% during the forecast period, with a market size of USD 30.01 million in 2025.
The Taiwan Insulin Pumps Market is projected to witness growth at a CAGR of 10.8% during the forecast period, with a market size of USD 58.52 million in 2025.
The South East Asia Insulin Pumps Market is projected to witness growth at a CAGR of 11.8% during the forecast period, with a market size of USD 99.03 million in 2025.
The Rest of APAC Insulin Pumps Market is projected to witness growth at a CAGR of 10.8% during the forecast period, with a market size of USD 67.52 million in 2025.
According to Cognitive Market Research, the global Insulin Pumps Market size was estimated at USD 439.7 Million, out of which South America held the market share of around 5% of the global revenue with a market size of USD 237.57 million in 2025 and will grow at a compound annual growth rate (CAGR) of 8.0% from 2025 to 2033.
According to Cognitive Market Research, the Brazil Insulin Pumps Market size was valued at USD 101.68 million in 2025 and is projected to grow at a CAGR of 8.6% during the forecast period. Growing investments in diabetes care startups are accelerating innovation in insulin delivery solutions.
Argentina's Insulin Pumps Market had a market share of USD 39.91 million in 2025 and is projected to grow at a CAGR of 8.9% during the forecast period. Favorable regulatory approvals are allowing faster market entry of new and advanced insulin pumps.
The Colombia Insulin Pumps Market is projected to witness growth at a CAGR of 7.8% during the forecast period, with a market size of USD 21.14 million in 2025
The Peru Insulin Pumps Market is projected to witness growth at a CAGR of 8.2% during the forecast period, with a market size of USD 19.48 million in 2025.
The Chile Insulin Pumps Market is projected to witness growth at a CAGR of 8.3% during the forecast period, with a market size of USD 17.10 million in 2025
The Rest of South America's Insulin Pumps Market is projected to witness growth at a CAGR of 7.1% during the forecast period, with a market size of USD 38.25 million in 2025.
According to Cognitive Market Research, the global Insulin Pumps Market size was estimated at USD 473.3 Million, out of which the Middle East held the major market share of around 2% of the global revenue with a market size of USD 250.07 million in 2025 and will grow at a compound annual growth rate (CAGR) of 8.3% from 2025 to 2033..
The Qatar Insulin Pumps Market is projected to witness growth at a CAGR of 7.8% during the forecast period, with a market size of USD 20.01 million in 2025. Rising disposable income in emerging economies is improving access to premium health devices like insulin pumps.
The Saudi Arabia Insulin Pumps Market is projected to witness growth at a CAGR of 8.6% during the forecast period, with a market size of USD 88.03 million in 2025.
The Turkey Insulin Pumps Market is projected to witness growth at a CAGR of 8.9% during the forecast period, with a market size of USD 20.01 million in 2025. Increased use of mobile health applications is facilitating real-time glucose monitoring and insulin management.
The UAE Insulin Pumps Market is projected to witness growth at a CAGR of 8.8% during the forecast period, with a market size of USD 51.51 million in 2025.
The Egypt Insulin Pumps Market is projected to witness growth at a CAGR of 8.1% during the forecast period, with a market size of USD 15.00 million in 2025.
The Rest of the Middle East Insulin Pumps Market is projected to witness growth at a CAGR of 7.5% during the forecast period, with a market size of USD 55.52 million in 2025
According to Cognitive Market Research, the global Insulin Pumps Market size was estimated at USD 268.1 Million, out of which the Africa held the major market share of around 2% of the global revenue with a market size of USD 137.54 million in 2025 and will grow at a compound annual growth rate (CAGR) of 8.7% from 2025 to 2033..
The Nigerian Insulin Pumps Market is projected to witness growth at a CAGR of 8.9% during the forecast period, with a market size of USD 11.00 million in 2025. Chronic diabetes complications are creating a need for better long-term glucose control tools.
The South Africa Insulin Pumps Market is projected to witness growth at a CAGR of 9.6% during the forecast period, with a market size of USD 48.41 million in 2025.
The Rest of Africa Insulin Pumps Market is projected to witness growth at a CAGR of 7.9% during the forecast period, with a market size of USD 78.12 million in 2025.
Global Insulin Pump Market Report 2025 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Insulin Pump Industry growth. Insulin Pump market has been segmented with the help of its Type Outlook:, Product Outlook: Accessories Outlook:, and others. Insulin Pump market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
How are Segments Performing in the Global Insulin Pumps Market?
According to Cognitive Market Research, Tethered insulin pumps possess the highest market share in the world insulin pumps market. They have a long history of trusting support from healthcare providers and patients with their dependable performance, reliability, and precise insulin delivery. Tethered pumps are commonly attached to the body by thin plastic tubing and allow users to have programmable basal and bolus doses, which can be precisely adjusted to suit specific insulin requirements. Based on evidence from the U.S. Centers for Medicare & Medicaid Services (CMS), tethered insulin pumps are extensively covered by reimbursement policies in the United States, facilitating their sustained superiority. Their cross-compatibility with continuous glucose monitoring (CGM) systems is another factor augmenting user confidence and clinical benefits. In the European nations of Germany and the UK, publicly funded health plans such as NHS England have added tethered pumps to public health offerings, and this has promoted their widespread adoption. Even as patch and smart pumps gain more popularity, the tethered category continues to be the most dominant because of its established infrastructure, high patient awareness, and extensive availability in clinics and hospitals.
Intelligent insulin pumps account for the Fastest-growth market segment in insulin pumps, motivated by advancements in wearable health devices and growing connectivity with digital health platforms. Such pumps employ complex algorithms, artificial intelligence-based functionality, and wireless communication to precisely manage insulin doses in real-time. Government subsidies towards digital healthcare revolution, specifically by agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), has hastened regulatory approvals and stimulated innovation. Furthermore, programs like the U.S. Health Information Technology for Economic and Clinical Health (HITECH) Act and EU4Health Programme in Europe have stimulated smart medical device adoption, such as connected insulin pumps. The capability of smart pumps to be paired with mobile apps and wearable CGM devices makes them extremely attractive to tech-savvy patients and the younger population. With healthcare systems moving toward individualized medicine, smart insulin pumps are experiencing quick growth in usage in both emerging and developed markets, especially in urban areas where there is a higher level of digital infrastructure.
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Insulin Pump Industry. Request a Free Sample PDF!
According to Cognitive Market Research, Medtronic's MiniMed, its leading insulin pump product line, continues to be the market-leading segment in the worldwide insulin pumps market because of its long-term existence, clinical trustworthiness, and brand excellence. The U.S. FDA's database of medical devices lists Medtronic's MiniMed pumps with numerous approvals and widespread applications in diabetes treatment at hospitals, clinics, and in the home environment. The U.S. and European-approved MiniMed 770G system is the first with hybrid closed-loop technology and continuous glucose monitoring (CGM) compatibility, and it is in the vanguard of automated insulin delivery systems. With robust post-market surveillance, training programs, and worldwide distribution networks supporting them, MiniMed pumps are regularly reimbursed under Medicare and Medicaid programs in the U.S., driving adoption. Moreover, government healthcare systems in nations such as Canada (Health Canada) and the UK (NHS) back Medtronic products, further cementing their dominance. Focusing on safety, innovation, and compatibility with digital platforms, MiniMed is the market leader, particularly among adults and pediatric patients who need sophisticated insulin management.
In the Insulin Pumps Market, Insulet Corporation's Omnipod tubeless insulin delivery system is the fastest-growing market with its simple design and convenience to wear. As opposed to older tethered pumps, the patch-style, water-resistant, wireless insulin pump system of Omnipod fascinates action users, even young children and teens. The U.S. Centers for Disease Control and Prevention (CDC) reports an increasing trend in the use of wearable medical devices, particularly among young diabetic patients. Omnipod DASH and Omnipod 5 systems have been cleared by the U.S. FDA, with the latter also combined with CGM for automated insulin adjustment. Insulet has also globalized, with approvals from European CE mark, Health Canada, and Therapeutic Goods Administration (TGA) Australia, driving growth in overseas markets at a faster rate. Telehealth programs supported by governments and digital health infrastructure, like the ONC Health IT program in the United States, further enhance Omnipod's acceptance. Omnipod's ease of use, freedom of mobility, and increasing trend towards patch pumps drive Omnipod's fast market penetration as well as rapid growth across the world.
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
According to Cognitive Market Research, Infusion sets are the leading segment in the insulin pump accessories market because of their critical function of insulin delivery from pump to patient. All insulin pump users need a dependable infusion set to deliver insulin subcutaneously, and thus, it is a non-negotiable element. Based on the U.S. Food and Drug Administration (FDA) and the Centers for Medicare & Medicaid Services (CMS), infusion sets qualify as durable medical equipment. They are reimbursed under insurance policies, thus promoting improved adoption rates. Infusion sets comprise tubing, a cannula, and connectors compatible with most popular insulin pumps, such as MiniMed, Omnipod (pod-specific systems), and Tandem. Furthermore, technology like fast-release and auto-insertion sets has enhanced convenience to the patient and lessened needle-associated anxiety, backed by medical research published through NIH and the CDC. The requirement of frequent replacement (every 2–3 days) also increases their repeated demand, making infusion sets the keystone accessory for insulin treatment.
In the Insulin Pumps Market, Insulin cartridges or reservoirs are the most rapid-growing accessory segment, fueled by increasing demand for easy, prefilled, and disposable insulin holding systems in pump devices. As insulin pump uptake increases worldwide—particularly smart and patch pumps—the demand for low-profile and high-capacity cartridges has grown. Based on the National Institutes of Health (NIH) and International Diabetes Federation (IDF) data, more than 537 million adults worldwide had diabetes in 2021, and insulin-dependent cases are increasing at a fast pace, especially among younger populations. Companies like Medtronic and Tandem provide proprietary cartridge designs to improve pump compatibility and insulin delivery effectiveness. Also, diabetes care programs that are supported by the government, such as the National Diabetes Prevention Program (CDC – USA) and NHS England's Diabetes Technology Funding, put a high focus on the user-friendliness of insulin delivery solutions. This has led healthcare professionals to suggest high-efficiency reservoirs with reduced refilling frequency and patient compliance, making this segment the fastest-growing segment.
According to Cognitive Market Research, Type I diabetes continues to be the leading application segment in the market for insulin pumps, mainly due to the fact that patients with this condition totally rely on exogenous insulin administration for survival. Type I diabetes, as stated by the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO), impacts about 5–10% of all people living with diabetes worldwide but requires regular insulin treatment from a very young age. The CDC's 2022 National Diabetes Statistics Report emphasizes that children and young adults with Type I diabetes are increasingly being recommended insulin pump therapy because it can more closely simulate physiological insulin release compared to multiple daily injections. Additionally, the U.S. Food and Drug Administration (FDA) has actively approved new pumps such as Tandem's Control-IQ and Medtronic's MiniMed 780G system, further encouraging use in this population. The lifetime dependence, along with the growing consciousness among parents and pediatric endocrinologists, guarantees high and stable adoption levels within this segment, and hence Type I diabetes remains the single largest contributor to market revenue.
In the Insulin Pumps Market, Type II diabetes is the most rapidly increasing category in the insulin pumps sector, fueled by increasing insulin dependency in more serious cases and a worldwide increase in the aging population. While handled traditionally with oral hypoglycemics, current recommendations issued by the American Diabetes Association (ADA) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) describe how a sizable majority of Type II patients come to need basal-bolus insulin therapy in the end. According to the CDC, almost 90–95% of diabetes cases in the U.S. are Type II, and a growing percentage of these patients are now embracing pump-based insulin delivery for improved glucose control. The ease and accuracy provided by newer smart pumps are particularly attractive to older patients and those with poor glycemic control on syringes. Additionally, public health organizations like NHS England and Australia's National Diabetes Services Scheme (NDSS) are increasing insurance coverage for pump therapy among Type II patients, increasing the adoption rate. These contribute to putting Type II diabetes in the lead position as the market's fastest-growing application segment.
Research Associate at Cognitive Market Research
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the medical devices & consumables industry. She has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services. Her expertise in Market Research and business intelligence has equipped her with the skills necessary to analyze complex information and provide strategic recommendations.
In her current role, Anushka is a highly motivated and detail-oriented research analyst with a passion for uncovering valuable insights from data. She thrives in dynamic environments where her analytical abilities and research expertise can contribute to informed decision-making for businesses. Her collaborative approach facilitated effective communication of insights, fostering a data-driven culture within the organization.Anushka remains an invaluable asset in the dynamic landscape of market research.
Conclusion
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Disclaimer:
Type Outlook: | Patch pumps, Tethered pumps, Smart insulin pumps, Traditional insulin pumps, Disposable insulin pumps |
Product Outlook: | MiniMed, Accu-Chek, Tandem, Omnipod, Others |
Accessories Outlook: | Insulin reservoirs or cartridges, Infusion sets, Infusion set insertion devices, Battery |
Application Outlook: | By Application:, Type I diabetes, Type II diabetes |
List of Competitors | Medtronic, Hoffmann-La Roche AG, Tandem Diabetes Care, Inc., Insulet Corporation, Ypsomed, Sanofi S.A., Sooil development, Jiangsu Delfu Co., Ltd., Cellnovo Ltd, Valeritas, Inc |
This chapter will help you gain GLOBAL Market Analysis of Insulin Pump. Further deep in this chapter, you will be able to review Global Insulin Pump Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
This chapter will help you gain North America Market Analysis of Insulin Pump. Further deep in this chapter, you will be able to review North America Insulin Pump Market Split by various segments and Country Split.
Chapter 2 North America Market Analysis
This chapter will help you gain Europe Market Analysis of Insulin Pump. Further deep in this chapter, you will be able to review Europe Insulin Pump Market Split by various segments and Country Split.
Chapter 3 Europe Market Analysis
This chapter will help you gain Asia Pacific Market Analysis of Insulin Pump. Further deep in this chapter, you will be able to review Asia Pacific Insulin Pump Market Split by various segments and Country Split.
Chapter 4 Asia Pacific Market Analysis
This chapter will help you gain South America Market Analysis of Insulin Pump. Further deep in this chapter, you will be able to review South America Insulin Pump Market Split by various segments and Country Split.
Chapter 5 South America Market Analysis
This chapter will help you gain Middle East Market Analysis of Insulin Pump. Further deep in this chapter, you will be able to review Middle East Insulin Pump Market Split by various segments and Country Split.
Chapter 6 Middle East Market Analysis
This chapter will help you gain Middle East Market Analysis of Insulin Pump. Further deep in this chapter, you will be able to review Middle East Insulin Pump Market Split by various segments and Country Split.
Chapter 7 Africa Market Analysis
This chapter provides an in-depth analysis of the market share among key competitors of Insulin Pump. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 9 Qualitative Analysis (Subject to Data Availability)
Segmentation Type Outlook: Analysis 2019 -2031, will provide market size split by Type Outlook:. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Type Outlook: Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by Product Outlook: Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by Accessories Outlook: Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 13 Market Split by Application Outlook: Analysis 2021 - 2033
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Insulin Pump market
Chapter 14 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Chapter 15 Research Methodology and Sources
Why Patch pumps have a significant impact on Insulin Pump market? |
What are the key factors affecting the Patch pumps and Tethered pumps of Insulin Pump Market? |
What is the CAGR/Growth Rate of MiniMed during the forecast period? |
By type, which segment accounted for largest share of the global Insulin Pump Market? |
Which region is expected to dominate the global Insulin Pump Market within the forecast period? |
Segmentation Level Customization |
|
Global level Data Customization |
|
Region level Data Customization |
|
Country level Data Customization |
|
Company Level |
|
Additional Data Analysis |
|
Additional Qualitative Data |
|
Additional Quantitative Data |
|
Service Level Customization |
|
Report Format Alteration |
|